SmithKline Beecham Corp acquires a minority stake in Idenix Pharmaceuticals Inc (pending)


US - SmithKline Beecham Corp, doing business as GlaxoSmithKline, a unit of GlaxoSmithKline PLC, agreed to acquire a #.##% stake, or #.### mil common shares, in Idenix Pharmaceuticals Inc, a a biopharmaceutical company, for $#.## per share, or

Deal Information

Credit & Investment Research

Market Research

News